布里莫尼丁作为近视的可能治疗方法
Zixuan Peng1,2, Aiqun Xiang1, Hong He3
1Hainan Provincial Key Laboratory of Ophthalmology, Hainan Eye Hospital, Zhongshan Ophthalmic Center, Sun Yat-sen University, No. 19 Xiuhua Road, Xiuying District, 570300, Haikou, Hainan, China.
BMC ophthalmology
|April 11, 2024
概括
布里莫尼丁有效地治疗了几内亚猪的形状缺失近视 (FDM),当通过子结膜或视膜内注射进行注射时. 这种治疗减少了近视,轴长和眼内压力 (IOP),突出了近视管理的潜力.
科学领域:
- 眼科医生 眼科 眼科
- 药理学 药理学是指药理学的学科.
- 临床前研究 临床前研究
背景情况:
- 近视是一个重大的全球公共卫生挑战.
- 了解近视的机制和潜在治疗方法至关重要.
研究的目的:
- 调查布里莫尼丁在治疗缺形近视 (FDM) 的疗效.
- 探索眼内压力 (IOP) 和近视进展之间的相关性.
主要方法:
- 形式剥夺近视 (FDM) 在几内亚猪中被诱导.
- 布里莫尼丁通过眼滴,眼膜下注射或各种度的视膜内注射进行施用.
- 眼内压力 (IOP),折射误差和轴长度 (AL) 被监测了21天.
主要成果:
- 结膜下和内内的布里莫尼丁显著抑制了FDM的发展.
- 有效的治疗方法减少了近视折射,轴延长和升高的内视压力.
- 眼科布里莫尼丁眼滴在治疗FDM时没有显示出有效性.
结论:
- 在临床前模型中,在特定的剂量和施用途径下,布里莫尼丁可以有效地减少FDM的发展.
- 眼内压力 (IOP) 的波动可能与缺形近视的进展有关.
相关概念视频
Open Angle Glaucoma: Treatment
440
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
440
Angle Closure Glaucoma: Treatment
485
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
485
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
794
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
794
Focusing of Light in the Eye
2.7K
Light rays enter the eye through the cornea, a transparent dome-shaped tissue that is the eye's outermost layer. The cornea bends or refracts, light rays traveling to the pupil. The shape of the cornea determines how much of the light is bent and whether the image will be focused correctly on the retina at the back of the eye. Once the light has passed through both refraction layers, it converges into a single focal point onto a small area. This is where photoreceptors start transforming...
2.7K
Glaucoma: Overview
560
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
560
Direct-Acting Cholinergic Agonists: Therapeutic Uses
731
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
731


